Prehypertension in dyslipidemic individuals; relationship to metabolic parameters and intima-media thickness

David Karasek1, Helena Vaverkova, Milan Halenka

  • 1Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, University Hospital Olomouc, Czech Republic. david.karasek@fnol.cz

Insights

Prehypertension and hypertension are more common in individuals with dyslipidemia, particularly hypertriglyceridemia. These conditions are linked to increased intima-media thickness, indicating higher cardiovascular risk.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Syndrome

Background:

  • Prehypertension, like hypertension, is a risk factor for cardiovascular disease.
  • Dyslipidemia is a common metabolic disorder associated with increased cardiovascular risk.

Purpose of the Study:

  • To determine the prevalence of prehypertension and hypertension across different dyslipidemic phenotypes.
  • To examine the relationship between blood pressure and other atherosclerotic risk factors.
  • To assess the atherogenic impact of prehypertension using carotid intima-media thickness (IMT).

Main Methods:

  • 667 asymptomatic subjects were categorized into four dyslipidemic phenotypes based on apolipoprotein B (apoB) and triglycerides (TG) levels.
  • Dyslipidemic Phenotype 1 (DLP1) with normal apoB/TG served as the control group.
  • Measurements included blood pressure, lipid profiles, and carotid IMT.

Main Results:

  • Prehypertension and hypertension were significantly more prevalent in all dyslipidemic groups compared to the normolipidemic control group.
  • Blood pressure correlated with age, lipids, BMI, and waist circumference, with specific correlations for SBP and DBP with other metabolic markers.
  • Intima-media thickness (IMT) was elevated in prehypertensive and hypertensive subjects across all dyslipidemic phenotypes.

Conclusions:

  • Dyslipidemia is associated with a higher prevalence of prehypertension and hypertension.
  • Hypertriglyceridemic individuals exhibited the highest combined prevalence of prehypertension and hypertension.
  • Elevated IMT in prehypertensive and hypertensive individuals underscores their increased cardiovascular risk.
Abstract

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...